Connect

Member Research and Reports

Member Research and Reports

Michigan Researcher Addresses How Women Make Breast Cancer Treatment Choices

More breast cancers are being caught in an early, curable stage, and about half of the 280,000 people diagnosed this year will have a particularly favorable prognosis. Despite their good prognosis, many of these patients will receive aggressive treatments that could have little to no effect on their survival. Overtreatment can include chemotherapy (and all its incumbent side effects) or more extensive surgery (and its additional risks and more difficult recovery). Two breast cancer researchers, Dr. Steven Katz, professor at the University of Michigan School of Public Health, and Dr. Monica Morrow, chief of the breast surgical service at Memorial Sloan-Kettering Cancer Center, outline the concerns about overtreatment in two separate commentaries published this week.